ViroGates A/S, an in vitro diagnostics company, develops and sells blood tests for measuring chronic inflammation for the healthcare sector. It offers suPARnostic, a proprietary biomarker used in hospital clinics to guide and inform individuals of their health state, and in hospitals to support clinical decisions and identify high-risk patients, as well as used for a range of acute and chronic health issues, such as cardiovascular disease, type 2 diabetes, and cancer. The company’s product includes suPARnostic TurbiLatex, a latex particle-enhanced turbidimetric immunoassay that quantitatively determines the soluble urokinase plasminogen activator receptor (suPAR) level in human K2-EDTA- or lithium heparin plasma samples; suPARnostic ELISA that provides fully quantitative results; and suPARnostic Quick Triage kit for use in the point of care situation for early warning and patient triaging that allows clinicians and nurses to obtain a fast patient prognosis for patient disease severity, progression, and outcome. ViroGates A/S was founded in 2000 and is headquartered in Birkerød, Denmark.
तुलना करने के लिए मीट्रिक्स | VIROG | क्षेत्र सेक्टर - संबंधित क्षेत्र की कंपनियों के व्यापक समूह से मेट्रिक्स का औसत हेल्थकेयर | संबंध संबंधVIROGपीअर्सक्षेत्र | |
|---|---|---|---|---|
पी/ई अनुपात | −9.9x | 32.4x | −0.6x | |
PEG अनुपात | −0.45 | −1.67 | 0.00 | |
क़ीमत/बुक | 43.4x | 3.0x | 2.6x | |
क़ीमत / एलटीएम बिक्री | 15.2x | 3.0x | 3.3x | |
अपसाइड (विश्लेषक लक्ष्य) | - | 9.3% | 39.8% | |
उचित मूल्य अपसाइड | अनलॉक करें | 9.2% | 4.3% | अनलॉक करें |